Action plan for determining and monitoring the prevalence of chronic kidney disease-Reference-Cited by-同舟云学术

Action plan for determining and monitoring the prevalence of chronic kidney disease

Published:2017-10 Issue:2 Volume:7 Page:63-70
ISSN:2157-1716
Container-title:Kidney International Supplements
language:en
Short-container-title:Kidney International Supplements

Author:

Coresh Josef,Hu Jiun-Ruey,Bello Aminu K.,Feldman Harold I.,Fogo Agnes B.,Ganji Mohammad Reza,Harris David C.,Levey Andrew S.,Okpechi Ikechi G.,Stengel Benedicte,Thomas Bernadette,Wiecek Andrzej,Gansevoort Ron T.

Publisher

Elsevier BV

Subject

Nephrology

Reference52 articles.

1. Levin A, Tonelli M, Bonventre J, et al: Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy [e-pub ahead of print]. Lancet. http://dx.doi.org/10.1016/S0140-6736(17)30788-2. Accessed May 1, 2017.

2. Global prevalence of chronic kidney disease – a systematic review and meta-analysis;Hill;PLoS ONE,2016

3. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO);Levey;Kidney Int,2005

4. A systematic analysis of world-wide population-based data on the global burden of chronic kidney disease in 2010;Mills;Kidney Int,2015

5. Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study;Ene-Iordache;Lancet Glob Health,2016

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ferric citrate for the treatment of hyperphosphatemia and iron deficiency anaemia in patients with NDD-CKD: a systematic review and meta-analysis;Frontiers in Pharmacology;2024-03-07

2. Ferric citrate’s efficacy for hyperphosphatemia and anemia in NDD-CKD: a meta-analysis;Third International Conference on Biological Engineering and Medical Science (ICBioMed2023);2024-01-08

3. Burden of end-stage renal disease of undetermined etiology in Africa;Renal Replacement Therapy;2023-09-05

4. NAU - New Areas of Unifying interest for CKD. A multidisciplinary expert opinion using the Jandhyala method (Preprint);2022-12-23

5. P2Y12 inhibitor clopidogrel inhibits renal fibrosis by blocking macrophage-to-myofibroblast transition;Molecular Therapy;2022-09